MedTrace Logo

Lateral Lymph Node Dissection for Middle-low Rectal Cancer

NCT03826862 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2019-02-01

No results posted yet for this study

Summary

The investigators will perform CT three-dimension reconstruction for middle-low rectal cancer patients who have enlarged lateral lymph nodes to recognize the variance of pelvic vessels, by which to help reduce operative time and blood loss, localize the lateral lymph nodes, improve the lymph node harvested and positive rate. Besides, The investigators will label the vessels near the interested node to achieve node-by-node for further investigation.

Conditions

Interventions

RADIATION

CT three-dimensional reconstruction

All patients will receive CT three dimensional reconstruction before surgery

Sponsors & Collaborators

  • Ziqiang Wang,MD

    lead OTHER

Principal Investigators

  • Ziqiang Wang, MD · Department of Gastrointestinal Surgery, West China Hospital, Sichuan University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2020-12-31
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03826862 on ClinicalTrials.gov